ROLAND BERECZ
ROLAND BERECZ
Afiliación desconocida
Dirección de correo verificada de keri.hu
Título
Citado por
Citado por
Año
Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease
A Égerházi, R Berecz, E Bartók, I Degrell
Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (3), 746-751, 2007
1932007
CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers
P Dorado, R Berecz, MJ Norberto, Ü Yasar, ML Dahl, A LLerena
European journal of clinical pharmacology 59 (3), 221-225, 2003
1252003
QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations
A Llerena, R Berecz, P Dorado, A de la Rubia
Journal of psychopharmacology 18 (2), 189-193, 2004
932004
Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients
JA Carrillo, SI Ramos, AG Herraiz, A Llerena, JAG Agundez, R Berecz, ...
Journal of clinical psychopharmacology 19 (6), 494-499, 1999
871999
Cognitive functions in prepsychotic patients
E Bartók, R Berecz, T Glaub, I Degrell
Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (4), 621-625, 2005
852005
Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions
A LLerena, P Dorado, R Berecz, AP González, EM Peñas-LLedó
European journal of clinical pharmacology 59 (12), 869-873, 2004
792004
Antibiotic use in 3 European university hospitals
RA Kiivet, ML Dahl, A Llerena, M Maimets, B Wettermark, R Berecz
Scandinavian journal of infectious diseases 30 (3), 277-280, 1998
741998
QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients
A LLerena, R Berecz, A de la Rubia, P Dorado
Journal of psychopharmacology 16 (4), 361-364, 2002
702002
Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype
R Berecz, A de la Rubia, P Dorado, P Fernández-Salguero, ML Dahl, ...
European journal of clinical pharmacology 59 (1), 45-50, 2003
662003
Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients
A LLerena, P Dorado, R Berecz, A González, MJ Norberto, A de la Rubia, ...
Journal of Chromatography B 783 (1), 25-31, 2003
642003
The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions
R Berecz, P Dorado, ADL Rubia, MC Caceres, I Degrell, A LLerena
Current drug targets 5 (6), 573-579, 2004
622004
Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions
A LLerena, R Berecz, P Dorado, CS de la Garza, MJ Norberto, M Cáceres, ...
Journal of Chromatography B 783 (1), 213-219, 2003
572003
Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes
A LLerena, R Berecz, A de la Rubia, P Fernández-Salguero, P Dorado
Therapeutic drug monitoring 23 (6), 616-620, 2001
542001
Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients
R Berecz, A LLerena, A De La Rubia, J Gomez, M Kellermann, P Dorado, ...
Pharmacopsychiatry 35 (06), 231-234, 2002
492002
Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity
A Llerena, R Berecz, A de la Rubia, MJ Norberto, J Benítez
Therapeutic drug monitoring 22 (4), 397-401, 2000
462000
Pharmacogenetics of clinical response to risperidone
A LLerena, R Berecz, E Peñas-LLedó, Á Süveges, H Fariñas
Pharmacogenomics 14 (2), 177-194, 2013
412013
Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs
P Dorado, R Berecz, EM Penas-Lledo, MC Caceres, A Llerena
Current drug targets 7 (12), 1671-1680, 2006
362006
Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios
P Dorado, R Berecz, MC Cáceres, A LLerena
Journal of Chromatography B 789 (2), 437-442, 2003
362003
P300 in mild cognitive impairment and in dementia
A Egerházi, T Glaub, P Balla, R Berecz, I Degrell
Psychiatria Hungarica: A Magyar Pszichiátriai Társaság Tudományos Folyóirata …, 2008
352008
Reduced completed suicide rate in Hungary from 1990 to 2001: relation to suicide methods
R Berecz, M Cáceres, A Szlivka, P Dorado, E Bartók, E Peñas-LLedó, ...
Journal of affective disorders 88 (2), 235-238, 2005
352005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20